A major concern for those intending to bring cell and gene therapy products to market is the manufacturing needs as the product moves from small- to large-scale.
In order to keep up with these changes, focus must be given to the eventual scale of production and shift from R&D to GMP compliance.
This webinar will provide an introduction to the regulatory framework for cell and gene therapies and highlight the importance of chemistry, manufacturing and controls.
Watch this webinar to learn about:
- Regulatory concerns
- Safety and quality testing throughout the product lifecycle
- Key acronyms and terminology